Giotrif 50 mg, Filmtabletten - 28 Swissmedic Key 63042004 Registration Holder Boehringer Ingelheim (Schweiz) GmbH Name Giotrif 50 mg, Filmtabletten Date of registration 17.01.2014 Introduction of Sequence 27.09.2017 ATC-Classification Afatinib (L01EB03) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.10. Show package size 28 Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680630420046 Medication Code Synthetika Pharmacode Disponibility
Composition afatinibum 50 mg ut afatinibi dimaleas, lactosum monohydricum 309.65 mg, cellulosum microcristallinum, silica colloidalis anhydrica, crospovidonum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, titanii dioxidum, talcum, E 132, polysorbatum 80, pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Afatinibum 50 mg
Inactive agents Dose additional_information Cellulosum Microcristallinum Crospovidonum E 132 color. Hypromellosum Überzug Lactose Monohydrate 309.65 mg Macrogol 400 Magnesii Stearas Polysorbatum 80 Pro Compresso Obducto Silica Colloidalis Anhydrica Talcum Titanium Dioxide
Source Data was imported : 08.11.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
